Cells lacking an intact ATM gene are hypersensitive to ionizing radiation and show multiple defects in the cell cycle-coupled checkpoints. DNA damage usually triggers cell cycle arrest through, among other things, the activation of p53. Another DNA-damage responsive factor is NF-kB. It is activated by various stress situations, including oxidative stress, and by DNAdamaging compounds such as topoisomerase poisons. We found that cells from Ataxia Telangiectasia patients exhibit a defect in NF-kB activation in response to treatment with camptothecin, a topoisomerase I poison. In AT cells, this activation is shortened or suppressed, compared to that observed in normal cells. Ectopic expression of the ATM protein in AT cells increases the activation of NF-kB in response to camptothecin. MO59J glioblastoma cells that do not express the DNA-PK catalytic subunit respond normally to camptothecin. These results support the hypothesis that NFkB is a DNA damage-responsive transcription factor and that its activation pathway by DNA damage shares some components with the one leading to p53 activation.
Introduction
Cell response to injury caused by physical or chemical agents includes an early stage at which latent transcription factors are activated. Among the most important ones are AP-1, p53 and NK-kB. Activation of AP-1 in response to ultraviolet radiation, for instance, invokes the activation of the c-Jun Nterminal Kinases (JNKs) (Liu et al., 1996a; Sachsenmaier et al., 1994) . The JNKs phosphorylate heterodimeric factors comprising one c-Jun subunit, such as AP-1 (the c-Jun/c-Fos heterodimer), raising their transactivation potential. Activation of p53 in response to genotoxic stress causes phosphorylation of its N-terminus, preventing its degradation (Agarwal et al., 1998; Shieh et al., 1997) . NF-kB is a heterodimer of two proteins belonging to the Rel family, p65/RelA and p50/NFkB1 (May and Ghosh, 1998; . It is maintained inactive in the cytoplasm of mammalian cells, bound to a protein of the IkB family that masks its nuclear localization signal. Activation of NF-kB usually needs the degradation of the IkB protein, itself triggered by phosphorylation on two serines in its N-terminus (DiDonato et al., 1997; May and Ghosh, 1998) . The NF-kB dimer is then translocated to the nucleus and binds to its response elements. Target genes of NF-kB include genes encoding cytokines, acute phase proteins, adhesion molecules, enzymes and viral proteins.
Ataxia Telangiectasia (AT) is an autosomal recessive disorder characterized by cerebellar ataxia, oculocutaneous telangiectasia, developmental abnormalities, progressive neurodegeneration, immunode®ciency, chromosomal instability, premature ageing and predisposition to cancer (Lavin and Shiloh, 1997; Shiloh, 1997) . Cells from patients suering from AT are hypersensitive to ionizing radiation and show multiple defects in activating the cell cycle checkpoints in response to ionizing radiation-induced DNA damage. Among other things, absent, delayed or reduced p53 activation has been described (Lu and Lane, 1993; Kastan et al., 1992) . All AT patients seem to exhibit mutations in the ATM (Ataxia Telangiectasia Mutated) gene (Gilad et al., 1996; Savitsky et al., 1995; Wright et al., 1996) , and mice with a knock-out of the ATM gene show a phenotype that recapitulates the AT syndrome (Xu and Baltimore, 1996) . The ATM gene encodes a large (350 kDa) protein with a C-terminal part having a signi®cant homology with the kinase domain of the Phosphatidyl-Inositol 3-Kinase (PI3-K) (Savitsky et al., 1995) . Other proteins that share such an homology with the PI3-K in their C-terminal part, like the DNAPKcs, mTOR, FRAP . . ., are involved in the control of the cell cycle or in the response to DNA damage (Hoekstra, 1997) .
NF-kB activity is deregulated in AT group D transformed ®broblasts, and the AT phenotype can be complemented by a truncated IkBa protein, that also restores a low level of NF-kB activity in these AT cells as well as the ability to activate NF-kB in response to ionizing radiation (Jung et al., 1995) . This suggests that the hypersensitivity of AT cells to ionizing radiation might be linked to their incapacity to activate NF-kB in response to stress. It was shown recently that ATM and the DNA-PK are serine-protein kinases, able to phosphorylate p53 and the nuclear tyrosine kinase c-Abl in vivo, and the IkB-a protein in vitro (Canman et al., 1998; Banin et al., 1998; Woo et al., 1998; Jung et al., 1997; Baskaran et al., 1997; . The c-Abl kinase can interact with and phosphorylate p53 (Goga et al., 1995) and the DNA-PK , and promotes cell cycle arrest in G1 through inhibition of the cyclin-dependent kinase Cdk2 (Yuan et al., 1996; Sawyers et al., 1994) . The p53 protein has a role both in arrest of the cell cycle through activation of the p21/WAF/CIP1 gene, and probably in triggering apoptosis (Agarwal et al., 1998; Dulic et al., 1994) . However, cell lines that lack a functional p53 can also undergo cell cycle arrest through p21 production, or apoptosis, after some types of stress (Liu and Zhang, 1998; Santana et al., 1996; Qiu et al., 1996; Gartenhaus et al., 1996) . NF-kB activation by oxidative stress has been widely documented (Sen and Packer, 1996; FloheÂ et al., 1997; Piette et al., 1997) , and there is overwhelming evidence that oxidative stress causes DNA damage (Friedberg et al., 1995) , mainly under the form of oxidized nucleic bases (like oxidation of guanine to 8-oxo-guanine), and strand breaks (leaving for instance a 3-phosphoglycolate terminus (Bertoncini and Meneghini, 1995) ). We and others have shown previously that DNA-targeted lesions, probably strand breaks, activate NF-kB in leukaemic cells (Piret and Piette, 1996; Legrand-Poels et al., 1995; Brach et al., 1991; Kasibhatla et al., 1998) . Other types of DNA-damaging agents can also activate NF-kB in some cell types (Quinto et al., 1993; Stein et al., 1989) .
Several recent reports argue that NF-kB activation can prevent the triggering of apoptosis in cells in response to stress (Van Antwerp et al., 1996; Beg and Baltimore, 1996; Liu et al., 1996b) . One suggested mechanism is the up-regulation of the production of caspase inhibitors (Chu et al., 1997) . Some observations also suggest that, in some cell types, NF-kB activation does not in¯uence, or might even promote apoptosis following cellular damage (Kasibhatla et al., 1998; Cai et al., 1997) .
Camptothecin (CPT) is a DNA-damaging drug belonging to the class of topoisomerase I poisons (Rothenberg, 1997; . It traps the topoisomerase I enzyme once it has performed a nick in a DNA strand, and prevents the religation of the nick (Froelich-Ammon and Oshero, 1995) . Subsequent interaction of the DNA-topoisomerase I-CPT complex with a replication fork or a transcription machinery causes the breakage of DNA (double-strand breaks) (Froelich-Ammon and Oshero, 1995; Nitiss and Wang, 1996) and leads to cell death.
In this work, we investigated the activation of NF-kB in response to CPT treatment, in cells that lack some component of the transduction machinery activated by DNA damage: ATM, the DNA-PKcs, and p53.
Results
Activation of NF-kB by CPT in p53-null and DNA-PKcs-null cells
We observed previously that CPT was able to activate the transcription factor NF-kB in various leukaemic cell lines: CEM, ACH-2 (an HIV-1 latently infected CEM clone) and Wurzburg (a Jurkat subclone) (Piret and Piette, 1996) . We have also observed, using transient transfections assays, that a 1 ± 4-h treatment with CPT can enhance the transcription of a reporter gene driven by kB elements in murine ®broblasts (Piret et al., unpublished results) . Figure 1 shows that CPT activates NF-kB in HL-60 myeloleukaemic cells within 1 h (Figure 1a) , and that this activation lasts for at least 4 h. A fast-migrating complex can be detected in extracts from untreated cells, and disappears progressively upon treatment with CPT, while the NF-kB complex appears. This phenomenon was observed in several leukaemic cell lines (Piret and Piette, 1996) , but not in adherent cells. The identity of this fast-migrating complex is unknown; competition experiments showed previously that it did not bind speci®cally to kB elements . Micromolar concentrations of CPT are sucient to activate NF-kB in HL-60 cells, and several complexes (up to three in some experiments) are induced (Figure 1b) , as we had previously observed in CEM cells. However, supershift experiments (with a limited number of antibodies) had revealed only the presence of NFkB1 (p50) and RelA (p65) in the complexes (Piret and Piette, 1996) . HL-60 cells do not express p53 (Planchon et al., 1995) and this suggests that, although p53 has been described to detect by itself some types of DNA damage (Jayaraman and Prives, 1995; Lee et al., 1995; Reed et al., 1995) , it is not the sensor of the lesions leading to NF-kB activation.
We then investigated the potential role of the nuclear protein kinase DNA-PK (Hartley et al., 1995) . For this we used MO59J and MO59K cells. They originate from the same tumour, but MO59J do not express the catalytic subunit of the DNA-PK (DNA-PKcs) . Figure 2a shows that NF-kB is activated in both cell lines after 1 h of treatment with CPT (lanes 3 and 8). The activation reaches similar levels and lasts for at least 5 h in both cell lines (compare lanes 3 ± 5 with lanes 8 ± 10). Phorbol Myristate Acetate (PMA), used as a positive control (lanes 2 and 7), was also equally potent in MO59J and in MO59K cells. Micromolar concentrations of CPT are sucient to activate NF-kB in both cell lines (Figure 2b ), like in HL-60 cells. Thus the DNA-PKcs is apparently not involved in this response to CPT, but one cannot exclude that Ku, the regulating subunit of DNA-PK, is involved in this response, since it binds to double-strand DNA-ends (Lees-Miller, 1996) .
Defective NF-kB activation by CPT in AT cells NF-kB is also activated by 10 mM CPT in MRC-5 human embryonic ®broblasts (Figure 3a , compare lane 1 with lanes 3 ± 5) with kinetics similar to those observed in the cell lines studied previously (compare Figure 3a with Figures 1a and 2a) . However, NF-kB is not activated by CPT in AT5BI cells (compare lane 6 with lanes 8 ± 10), which are primary ®broblasts from an AT patient belonging to the pseudo-complementation group D (Jaspers et al., 1988) . We measured ( Figure 3b ) the activity of topoisomerase I (the target of CPT) in MRC-5 and in AT5BI cells with the DNA relaxation assay (Liu and Miller, 1981) and found a similar activity in both cell lines. Relaxing activity in AT5BI cells was 25+6 ng DNA/mg proteins/h (mean+s.d.), versus 27+10 ng DNA/mg proteins/h in MRC-5 cells (®ve independent experiments), and the dierence is not signi®cant (P=0.689, paired, twotailed, student's t-test). Thus the lack of eect of CPT in AT5BI cells cannot be attributed to a lack of topoisomerase I activity. Tumour Necrosis Factor-a (TNF-a) is a strong activator of NF-kB in both cell lines ( Figure 3a , lanes 2 and 7), showing that NF-kB proteins are expressed at normal levels in AT5BI cells. Therefore a possible explanation is that the genetic alterations causing the AT phenotype could also aect the ability to activate NF-kB in response to treatment with a DNA-damaging drug.
To see if the lack of sensitivity to CPT at the NF-kB level is a common feature in Ataxia Telangiectasia cells, we used other AT primary cell lines. Most of the lines that we used have at least one mutation of the ATM gene described and/or their complementation group determined (see Table 1 ). Activation of NF-kB could be detected in the two normal ®broblastic cell lines tested (MRC-5 and GM38B) ( Figure 4a , lanes 1 ± 2 and 13 ± 14). Some activation could also be detected after 90 min in primary ®broblasts from several AT patients (AT20IJE-F, GM8391 and AT19IJE-F, see lanes 4 ± 5, 16 ± 17 or 19 ± 20). Interestingly, all cell lines also respond to a 2-h treatment with the anticancer drug daunomycin (see lanes 3, 6, 9, 12, 15, 18 and 21), a drug that causes DNA damage (through topoisomerase II poisoning), free radical generation, and ceramide production (Baguley, 1991; Bose et al., 1995) . All these signals have previously been reported to activate NF-kB (Piret and Piette, 1996; Schreck et al., 1991; Singh and Agarwal, 1995) . All cell lines tested also respond to TNF-a ( Figure 4b , lanes 5 and 10 and data not shown). In AT5BI, AT19IJE-F, AT20IJE-F and GM8391 cells, the NF-kB activation by CPT was not always detected and was clearly dependent on the time of treatment. While in normal ®broblasts (GM38B and MRC-5) the NF-kB activity persisted for several hours (see Figures 3a and 4b ), the activation was transient and usually disappeared after 2 h in AT cells, and even decreased below the basal level after 3 or 4 h of CPT treatment ( Figure 4b , lanes 6 ± 9; Figure 6a , lanes 2 ± 4 and 6 ± 8). Thus primary AT ®broblasts exhibit a defect in NF-kB activation in response to a DNA-damaging drug, that recalls their defect regarding p53 activation in response to ionizing radiation. The decrease in NF-kB activation suggested that maybe a toxic eect, related to the hypersensitivity of AT cells to some DNA-damaging agents, could explain the lack of NF-kB activation after long treatments with CPT. So we tested whether the NFkB activation machinery was still intact in cells treated with CPT for long periods. In Figure 5 , cells were either treated with 250 U/ml TNF-a for 20 min, or with 10 mM CPT for 3.5 h, or with CPT for 3.5 h and then for an additional 20 min with TNF-a. Figure 5 shows that both AT and normal cells respond to TNF-a even when they had been previously treated with CPT for 3.5 h. Thus it is unlikely that a toxic eect, or an alteration of the NF-kB activation machinery, caused by CPT, is responsible for the defect in NF-kB activation observed in AT cells.
IkBa degradation in normal and AT ®broblasts
We then investigated the ability of CPT to trigger phosphorylation and degradation of IkBa in cells. Cells were treated with TNF-a or with CPT, then the cytoplasmic and nuclear proteins were analysed by Western blotting (for IkBa detection) and by EMSA respectively. Figure 6a shows that TNF-a, a strong activator of NF-kB, causes the complete disappearance of IkBa both in normal and in AT cells (Figure 6a upper panel, lanes 1, 5 and 9). CPT causes a partial, not easily detectable, degradation of IkBa, both in AT Figure 3 Comparison of MRC-5 and AT5BI ®broblasts regarding NF-kB activation by CPT or TNF-a, and topoisomerase I activity. (a) Cells were either left untreated (lanes 1 and 6) or treated with 250 U/ml TNF-a for 30 min (lanes 2 and 7) or with 10 mM CPT for 1 h (lanes 3 and 8), 2 h (lanes 4 and 9) or 3 h (lanes 5 and 10). Nuclear proteins were then extracted and analysed by EMSA using a kB probe. (b) Nuclear protein extracts were serially diluted (1 : 2, from lane 2 to lane 10 and from lane 12 to lane 20, starting with 20 mg of protein in lanes 2 and 12. Samples in lanes 1 and 11 contained no proteins). The nuclear proteins were then allowed to react with 500 ng of supercoiled pM53 plasmid DNA for 1 h at 378C. The supercoiled (SC) and relaxed (R) forms of the plasmid were separated on an agarose gel, and their proportions were determined by densitometry of the photograph. Relaxing activity was measured in the linear range and calculated in ng pM53 DNA relaxed/mg protein/h. The values obtained for the two cell lines were (mean+s.d.): 25+6 for AT5BI, and 27+10 for MRC-5 (®ve independent experiments) and are not signi®cantly dierent (P=0.689 with the two-tailed, paired, student's t-test) Wright et al. (1996) ; Savitsky et al. (1996) See Wright et al. (1996) See Wright et al. (1996) ± ± MRC-5 and GM38B ®broblasts are supposed to express wild-type ATM protein. AT5BI, GM367, AT19IJE-F, AT20IJE-F and GM8391 are from AT patients. AT20IJE-F and AT5BI cells had been assigned to complementation groups C and D respectively (Jaspers et al., 1988) and in normal cells (Figure 6a upper panel, lanes 6 ± 7 and 10 ± 11; Figure 6b , lanes 6 ± 7 and 10 ± 11). Intriguingly, after 4 h, an increase in the levels of IkBa is observed both in normal and in AT cells, maybe resulting from NF-kB-enhanced transcription of the IkBa gene, while NF-kB activity persists in MRC-5 cells only (Figure 6a ; compare lanes 4 and 8 with lane 12). Phosphorylation of IkBa on Ser32 and Ser36 is Figure 4 Comparison of normal and AT primary ®broblasts regarding NF-kB activation in response to CPT and daunomycin.
(a) Cells of the indicated lineages were treated with 10 mM camptothecin (CPT) for 90 min or with 5 mM daunomycin (Dauno) for 2 h or left untreated, as indicated. (b) GM38B and AT20IJE-F (GM2531) cells were either left untreated (lanes 1 and 6) or treated with 10 mM CPT for 1 h (lanes 2 and 7), 2 h (lanes 3 and 8) or 3 h (lanes 4 and 9), or treated with 250 U/ml TNF-a for 30 min (lanes 5 and 10). Nuclear proteins were then extracted and analysed by EMSA with a kB probe. The arrow indicates the position of the speci®c NF-kB complex Figure 5 Eect of CPT treatment on the ability of cells to activate NF-kB in response to TNF-a. Cells of the indicated lineages were either left untreated, treated with 250 U/ml TNF-a for 20 min, or with 10 mM CPT for 3.5 h, or with 10 mM CPT for 3.5 h ®rst and then with 250 U/ml TNF-a for 20 min, as indicated. The nuclear protein were extracted and analysed by EMSA with a kB probe. The arrow indicates the position of the speci®c NF-kB complex commonly a prerequisite for its ubiquitination and degradation (May and Ghosh, 1998) . We used the protease inhibitor ALLN (N-Acetyl-Leucyl-LeucylNorleucinal) and phosphatase inhibitors (see Materials and methods) in an attempt to detect a phosphorylation-induced shift of IkBa (Alkalay et al., 1995) after treatment with CPT. Cells were treated with ALLN as indicated (Figure 6b ), then with TNF-a or CPT, and the cytoplasmic proteins were extracted in the presence of phosphatase inhibitors for analysis by Western blotting. Figure 6b shows that TNF-a-induced IkBa degradation is, at least in part, inhibited by ALLN, and that the remaining protein has a slower electrophoretic mobility (lanes 2 and 9) than in untreated cells, which can certainly be attributed to (hyper)phosphorylation. On the opposite, cells treated with ALLN and then with CPT (lanes 5 and 13) did not show this shift in IkBa protein mobility, suggesting that CPT does not cause phosphorylation of IkBa on Ser32 and Ser36. We could not determine whether protease inhibition could prevent CPT-induced NF-kB activation, because, in our hands, ALLN was unable to inhibit NF-kB activation by TNF-a completely (data not shown).
Eect of the ectopic expression of ATM on NF-kB activation
We also compared NF-kB activation by CPT in AT5BIVA cells (SV40-transformed AT5BI ®broblasts) and in wild-type SV40-transformed WI26VA4 fibroblasts, and obtained results similar to those with primary ®broblasts (Figure 7a , compare lanes 1 ± 4 with lanes 6 ± 9): a slight and transient NF-kB activation by CPT was observed in AT5BIVA cells, versus a stronger and sustained activation in WI26VA4 cells. Of note, a relatively high constitutive level of NFkB DNA-binding activity was detectable in both cell lines (Figure 7a, lanes 1 and 6) . Both cell lines also responded to daunomycin (Figure 7a , lanes 5 and 10) and TNF-a (not shown). We attempted to restore the function of the ATM protein in AT5BIVA cells by transfecting them with an expression vector containing the full ATM cDNA (Ziv et al., 1997) . Such an ectopic expression of the ATM protein was shown previously to restore some resistance to ionizing radiation and ability to arrest the cell cycle in response to DNA damage (Ziv et al., 1997; Zhang et al., 1997) . AT5BIVA cells were transfected with the episomal vector pEBS7-YZ5, containing the full ATM cDNA with the sequence for the FLAG tag, or with pEBS7 (control vector), and selected for hygromycin resistance for 4 weeks. The surviving populations were pooled and tested for presence of the recombinant ATM protein. Using the monoclonal M5 anti-FLAG antibody, expression of the recombinant FLAG-tagged ATM protein was detectable in cells transfected with the pEBS7-YZ5 plasmid ( Figure 7b , lane 2). The transfected cells were then tested for their ability to activate NF-kB in response to CPT treatment. As shown in Figure 7c and d, AT5BIVA cells transfected with the pEBS7-YZ5 vector show a stronger and longer NF-kB activation in response to CPT than do cells transfected with the empty vector pEBS7 (compare lanes 1 ± 4 with lanes 5 ± 8 in Figure 7c ) or than untransfected cells (Figure 7a ). Thus a defective NF-kB activation by the DNA-damaging drug CPT is another feature of the AT phenotype than can be complemented by re-introduction of the ATM gene, suggesting an important role for NF-kB in the early stage of the cellular response to DNA damage.
Discussion
The goal of our study was to clarify the role of DNA damage as an activator of NF-kB. The hypothesis that DNA damage, including that generated by topoisomerase poisons, is a trigger for NF-kB, is supported by many reports (Piret and Piette, 1996; Legrand-Poels et al., 1995; Brach et al., 1991; Kasibhatla et al., 1998; Quinto et al., 1993; Stein et al., 1989) but little insight in the activation pathway has been provided until now. CPT was used because, like ionizing radiation, it causes single-and double-strand breaks in cells, and no other eect than topoisomerase I poisoning has ever been described in intact cells for this drug. Many DNAdamaging agents (ionizing radiation, bleomycin, daunomycin, etoposide, mitomycin C . . .) generate reactive oxygen species that could activate NF-kB without a need for DNA damage (Anderson et al., 1994; Sinha and Mimnaugh, 1990) . Verhaegen et al. (1995) , using oxidation-activated¯uorescent probes, could not detect an increased reactive oxygen species (ROS) production in cells treated with CPT, and we detected no ROS production in CEM cells treated with CPT either, using electron paramagnetic resonance coupled with spin trapping (data not shown).
To elucidate the pathway leading to NF-kB activation following DNA damage, we used cell lines defective for components of a signalling pathway that was proposed recently for p53 (Brown and McCarthy, 1997) . Elements of this cascade include ATM, c-Abl, p53, the DNA-PK and p21. The nature of the primary sensor(s) of DNA damage caused by ionizing radiation and leading to p53 activation in human cells is unknown. Although it has been reported to detect by itself some types of damage (Jayaraman and Prives, 1995; Lee et al., 1995; Reed et al., 1995) , p53 is certainly not the sensor of the DNA lesions that trigger NF-kB, since HL-60 cells respond to CPT (Figure 1) , and they do not express p53 (Planchon et al., 1995) . The DNA-PKcs either does not seem to play a role in this activation, because a cell line de®cient in DNAPKcs does activate NF-kB in response to CPT as well as its DNA-PKcs-pro®cient counterpart (Figure 2) . Basu et al. (1998) recently observed that MO59J did not activate NF-kB in response to ionizing radiation, while MO59K did, suggesting that the DNA-PK does play a role in transduction from DNA damage to NFkB. The apparent discrepancy with our results may be explained by the dierences between the mechanisms by which ionizing radiation and CPT cause DNA damage into cells: strand breaks accumulate with time in cells treated with CPT, while they are generated instantly with ionizing radiation. In addition, these authors tested only a single dose of ionizing radiation (10 Gy). Higher or lower doses might reveal similar behaviour in both cell lines (Lu and Lane, 1993) .
Intriguingly, observed that defective DNA-PK activity in SCID cells resulted in higher constitutive NF-kB activity than in normal cells, rather than a lack of NF-kB activity. Besides this, we cannot exclude that Ku, the regulatory subunit of the DNA-PK, serves as the sensor of DNA lesions. Other candidates for the DNA damage-sensor(s) are some proteins of the Base Excision Repair system (X-ray Repair Cross-Complementation (XRCC) proteins), and the poly(ADP-ribose) polymerase (PARP). The PARP has already been implicated in NF-kB activation by some stimuli (Lepage et al., 1998) . Our future work will aim at determining the role of PARP in NF-kB activation by CPT.
From Table 1 and Figures 3 and 4 , it seems that, in primary cells, the age of the donor in¯uences the NFkB response to CPT. Embryonic MRC-5 cells respond better than GM38B, whose donor was 9 years old (compare Figure 3a with Figure 4b ). AT5BI and GM367 cells (donor age: 18) are nearly insensitive to CPT, while the other AT cells, whose donors are younger, show some degree of activation. One mechanism to explain these observations is suggested by the accelerated senescence typical of AT cells (Lavin and Shiloh, 1997; Vaziri et al., 1997) and by the role of telomeres. In a cell, the length of telomeres is presumably regulated by the number of divisions it has undergone (Harley et al., 1990) , and abnormal telomere maintenance (accelerated telomere shortening) exists in AT cells (Xia et al., 1996; Metcalfe et al., 1996; Pandita et al., 1995; Vaziri et al., 1997) . Thus if ATM has a role both in telomere maintenance (as suggested by a recent report (Smilenov et al., 1997) ) as well as in DNA damage signalling, one might speculate that in fact both processes use the same machinery. Ku, a DNA break-binding protein, also plays a role in telomere maintenance (Gravel et al., 1998; Boulton and Jackson, 1998) . Non-coding DNA regions such as the telomeres might be used by the cell as sensors for free radicals, detected under the form of DNA damage, taking advantage of the sensitiveness of DNA to chemical and physical agents.
The observation of an early and short NF-kB activation by CPT in some AT cell lines (Figure 4) suggests that ATM is not the primary sensor of the DNA lesions. But the shortening or the suppression of this activation in AT cells demonstrate that it is required for a sustained NF-kB activation. Topoisomerase I activity is normal in AT5BI cells compared to MRC-5 ®broblasts (Figure 3b ), arguing against a lack of DNA-damaging action of CPT in AT5BI cells. Interestingly, of several cDNAs that can complement some aspects of the AT (group D) phenotype, one encodes a truncated human topoisomerase III (Meyn et al., 1993; Fritz et al., 1997) .
TNF-a and daunomycin activate NF-kB in AT cells (Figure 4) , suggesting that they express normal amounts of NF-kB and IkB proteins. The activation by daunomycin, a topoisomerase II poison, is intriguing because daunomycin is often described to act primarily through DNA lesions which are similar, although not identical, to those caused by CPT. Topoisomerase I (trapped by CPT) generates nicks with 5'-OH and 3'-phosphotyrosine (linking the DNA to the enzyme) ends, and topoisomerase II (trapped by daunomycin) gives 5'-phosphotyrosine and 3'-OH ends. The nature of the secondary breaks generated after interaction with the DNA replication fork is unknown. Thus either the DNA lesions generated by daunomycin activate NF-kB through another pathway that does not involve ATM (due to dierence in the type of DNA lesions) or, more probably, daunomycin-mediated NFkB activation does even not involve nuclear damage (like UV-mediated NF-kB activation (Devary et al., 1993) ) but a cytoplasmic signal, such as ceramide production (Bose et al., 1995; JareÂ zou et al., 1996; Singh and Aggarwal, 1995) .
We were able to detect some degradation of IkBa in response to CPT in AT cells, as well as in normal cells (Figure 6 ). However, no phosphorylation-induced shift could be detected. So the degradation pathway for IkBa in response to CPT may be dierent from that triggered by other stimuli. Recently, Bender et al. (1998) showed that early UV-induced IkBa degradation did not require Ser32 and Ser36. Jung et al. (1998) suggested that, in response to ionizing radiation, caspase 1 and/or caspase 3 (rather than the proteasome), might cleave IkBa. Resynthesis of IkBa occurred both in normal and in AT cells. Thus, that sustained NF-kB activation requires ATM might be explained by several hypothesis: (i) sustained activation may require protein synthesis, that ATM could control (by an unknown mechanism); (ii) ATM, which can phosphorylate IkBa, might prevent newly synthesized IkBa from capturing DNA-bound NF-kB (and relocating it to the cytoplasm) when DNA damage persists in cells; (iii) ATM could trigger the mobilization of a second pool of NF-kB molecules, by enhancing the degradation of other IkB molecules than IkBa, such as IkBb and p105. However we have not been able to detect IkBb or p105 degradation in response to CPT in normal cells (data not shown); and (iv) at last, ATM could phosphorylate NF-kB and contribute to stabilize its binding to DNA, or prevent its capture by newly synthesized IkBa.
Can the defect of NF-kB activation in AT cells explain their hypersensitivity to ionizing radiation, since it was shown that NF-kB activation could prevent stress-caused apoptosis (Van Antwerp et al., 1996; Beg and Baltimore, 1996; Liu et al., 1996b) ? This is daring to speculate because both normal and AT transformed lymphoblasts show high constitutive NF-kB activity (data not shown), probably consecutive to maturation in B cells before EBV transformation, but AT lymphoblasts remain hypersensitive to ionizing radiation (Lavin and Shiloh, 1997) . In addition, some reports indicate that NF-kB does not aect or even promote programmed cell death in some systems (Kasibhatla et al., 1998; Hug et al., 1997) . Jung et al. (1998) recently showed that the N-terminally truncated IkBa protein that complements the AT phenotype in AT5BIVA cells (Jung et al., 1995) diminishes apoptosis in AT cells but enhances apoptosis in normal (MRC5-CV1) ®broblasts. Thus the role of NF-kB in ionizing radiation-induced apoptosis remains an open question.
Downstream targets of ATM leading to NF-kB are currently unknown. The c-Abl tyrosine kinase is a downstream target of ATM (Baskaran et al., 1997; Shafman et al., 1997) and can interact with p53 (Goga et al., 1995) and the DNA-PK , and its kinase activity is required for cell cycle arrest (Yuan et al., 1996) . The lack of involvement of p53 and DNA-PKcs in NF-kB activation is compatible with the pathway described above. Either ATM or cAbl could be the crossing point from which the pathways leading respectively to p53 and NF-kB diverge. Then, transduction of the signal from the nucleus to a cytoplasmic IkB kinase might involve activation of an enzyme located in the nuclear envelope, or translocation of a nuclear protein to the cytoplasm, or connection to the pathway involved in NF-kB activation by endoplasmic reticulum overload (Pahl and Baeuerle, 1995) .
Materials and methods
Cell lines, plasmids, chemicals and transfections MRC-5 embryonic lung human ®broblasts were from Biowhittaker (Verviers, Belgium). WI26VA4 human transformed ®broblasts were bought from the European Collection of Animal Cell Cultures (Salisbury, UK). MO59J and MO59K human glioblastoma cells were a kind gift of Dr J Turner (Cross Cancer Institute, Edmonton, Canada). AT ®broblasts (AT5BI, AT5BIVA, AT20IJE-F, AT19IJE-F, GM367, GM8391) and GM38 normal ®broblasts are from the Coriell Cell Repositories (Camden, New Jersey, USA). When possible, primary cells were used at similar passage. HL-60 myeloleukaemic cells were from the ATCC. Chemicals were from Sigma (Bornem, Belgium) unless otherwise stated.
Fibroblastic cell lines were cultured in EMEM+10% Foetal Calf Serum (FCS)+glutamine+antibiotics (penicillin/ streptomycin). Primary cells also received vitamins and nonessential amino-acids (all from Life Technologies, Gaithersburg, MD, USA). FCS was 20% for AT primary cells. MO59J and MO59K glioblastoma cells were cultured in HAM/F12 medium supplemented with vitamins, nonessential amino acids, 15% FCS, antibiotics and glutamine. HL-60 cells were cultured in RPMI 1640 medium+10% FCS+glutamine+antibiotics. CPT, PMA and daunomycin (either from ICN Biomedicals, Asse-Relegem, Belgium or from Sigma) were prepared in dimethylsulphoxide and stored at 7808C. ALLN (N-Acetyl-Leucyl-Leucyl-Norleucinal) was prepared in ethanol and stored at 7208C. TNF-a was from Boehringer (Mannheim, Germany). The expression vector pEBS7-YZ5 for the full length recombinant FLAG-tagged ATM protein and the empty (control) vector pEBS7 were kindly provided by Dr Y Shiloh (Tel Aviv University, Ramat Aviv, Israel) and are described elsewhere (Ziv et al., 1997; Peterson and Legerski, 1991) . Transformed ®broblastic AT5BIVA cells were transfected with plasmids pEBS7 and pEBS7-YZ5 using . From 48 h after the transfection and on, the cells were cultured in presence of 200 mg/ml hygromycin B (ICN Biomedicals, Asse-Relegem, Belgium). After 28 days, hygromycin-resistant cells were pooled and tested for expression of the ATM FLAG-tagged protein by Western blotting using the M5 anti-FLAG monoclonal antibody (Eastman Kodak Imaging Systems, New Haven, CT, USA) as described (Ziv et al., 1997) .
Cell treatment, protein extraction, IkBa detection and electrophoretic mobility shift assay (EMSA) Con¯uent cells were trypsinized, diluted in fresh medium and seeded 24 h before treatment with CPT. HL-60 cells were diluted at 5610 5 cells/ml. For exposure to CPT, the medium was either replaced by medium containing CPT, or CPT was added directly in the medium, without any dierence in the results. At indicated times after CPT addition, the cells were washed with Phosphate-Buered Saline (PBS), scraped, centrifuged and resuspended in 400 ml buer 1 (10 mM HEPES-KOH pH 7.9, 2 mM MgCl 2 , 0.1 mM EDTA, 10 mM KCl, 2 mM DTT (dithiothreitol), 0.5 mM phenylmethylsulphonyl¯uoride (PMSF), phosphatase inhibitors (5 mM NaF, 1 mM Na 3 VO 4 , 2 mM b-glycerophosphate, 1 mM p-nitrophenylphosphate and 200 nM okadaic acid) and COMPLETE 2 protease inhibitors (Boehringer)) for 15 min. NP-40 was then added to a ®nal concentration of 0.3%. The cells were vortexed for 5 s and the nuclei were pelleted by centrifugation at 15 000 g for 30 s. The supernatant was stored at 7808C for use as cytoplasmic extract for IkBa detection by Western blotting. The pellet of nuclei was resuspended in 15 ml buer 2 (50 mM HEPES-KOH pH 7.9, 50 mM KCl, 400 mM NaCl, 0.1 mM EDTA, 10% (v/ v) glycerol, 2 mM DTT, 0.5 mM PMSF, protease and phosphatase inhibitors) for 30 min and centrifuged at 15 000 g for 10 min. The supernatant, containing the nuclear proteins, was stored at 7808C. For recombinant ATM detection, whole cell extracts were obtained by incubating the scraped and PBS-washed cells in 60 ml of PBS containing 0.1% (w/v) SDS (sodium dodecylsulphate), 0.5% (w/v) sodium deoxycholate, 0.5% (v/v) NP-40 and 1 mM EDTA for 15 min on ice, and then centrifuging them at 15 000 g for 15 min. The protein concentration was assayed using the Bradford reagent (Biorad). EMSAs were performed as described previously using a DNA probe encompassing the kB sites of the HIV enhancer (Piret and Piette, 1996) . IkBa was detected by Western blotting as described previously using the MAD10B monoclonal antibody (Jaray et al., 1995) .
DNA-relaxing activity assay
Topoisomerase I activity was determined by the ability of nuclear extracts to relax supercoiled pM53 plasmid in vitro (Liu and Miller, 1981) . Serial dilutions of nuclear proteins were performed in buer 2 and mixed with 500 ng of supercoiled plasmid pM53 in buer 3 (10 mM KCl, 10 mM Tris-HCl pH 7.9 ± 8.0, 0.5 mM EDTA, 1 mM Na 3 VO 4 , 10 mM MgCl 2 ). The samples were then placed at 378C for 1 h. The reaction was stopped by adding proteinase K (100 mg/ml) and SDS (0.5%) and further incubation for 30 min. At last the reaction products were separated on a 1% agarose gel. The gel was photographed in the presence of ethidium bromide under UV light with a digital camera (UVP, Cambridge, UK), and the densities of the supercoiled and relaxed bands were determined on the photograph using the ImageQuant software version 4.2 (Molecular Dynamics). In each lane, the intensities of the supercoiled and relaxed fractions were compared to the total intensity for that lane, rather than to the intensity of the control (without protein) sample, to avoid the bias caused by non-uniform staining and/or illumination of the gel. Topoisomerase I activity in cell extracts was calculated in the linear range and expressed as: amount of pM53 DNA relaxed in 1 h divided by amount of proteins in the sample.
